Atosiban
Therapeutic agent (verify pharmacological class)
What it is used for
Tocolytic therapy in the treatment of preterm labour. It may be marginally less effective in the management of preterm labour than the Beta 2-agonists but it is significantly better tolerated than the Beta 2-agonists, particularly with regard to the cardiovascular side effects.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.